WS #16094
M&A activity is accelerating in biotech and industrial tech, with Merck KGaA acquiring Silence Therapeutics in an all-cash deal and TTM Technologies purchasing MKS Inc.'s optics business for $650 million. In the enterprise software and hardware space, Siemens is partnering with NVIDIA to advance autonomous factories, and Santander is building AI capabilities on NVIDIA infrastructure. These developments highlight continued capital allocation toward AI and biotech innovation despite broader market volatility.
Corporate M&A and Strategic Partnerships
M&A activity is accelerating in biotech and industrial tech, with Merck KGaA acquiring Silence Therapeutics in an all-cash deal and TTM Technologies purchasing MKS Inc.'s optics business for $650 million. In the enterprise software and hardware space, Siemens is partnering with NVIDIA to advance autonomous factories, and Santander is building AI capabilities on NVIDIA infrastructure. These developments highlight continued capital allocation toward AI and biotech innovation despite broader market volatility.